Asiantuntijamme ovat kirjoittaneet, osallistuneet ja antaneet näkemystä satoihin julkaisuihin.
Soini E. Cost-Effectiveness of Prevention: Alzheimer’s Disease and Hereditary Breast and Ovarian Cancer. Kuopio Health Insights 2024 – KHI2024 – Pharma Development & Digital Health: 13–14.8.2024.
Soini E. Welcome and Kuopio Health introduction. Kuopio Health Insights 2024 – KHI2024 – Pharma Development & Digital Health: 13–14.8.2024.
Apteekkien farmaseuttisen työn arvo. ESiOR Oy:n raportti 6.8.2024. Suomen Apteekkariliitto.
Oksanen M, Parviainen J, Asseburg C, Hageman S, Rissanen TT, Kivelä A, Taipale K, Visseren F, Martikainen J. Risk-Stratified Analysis of Long-Term Clinical Outcomes and Cumulative Costs in Finnish Patients with Recent Acute Coronary Syndrome or Coronary Revascularisation: A 5-Year Real-World Study Using Electronic Health Records. Eur Heart J Open 2024;
Soini E. AI and Machine Learning in HEOR. Value Health 2024;27:S1.
Soini E, Asseburg C, Jalkanen K, Pehrsson M, Lundström T, Meretoja T, Hautalahti M, Salminen E, Auranen A, Mäkelä J, Carpén O. Lifetime Cost-Effectiveness of Hereditary Breast and Ovarian Cancer Prevention Based on FinnGen and Biobank Data, Data Returning Process, and Prophylaxis. Value Health 2024;27:S1.
Lavikainen P, Heiskanen J, Jalkanen K, Lehtimäki AV, Vehkala S, Kangas P, Husman K, Vohlonen I, Martikainen J. Effectiveness of the Coordinated Return to Work model after orthopaedic surgery for lumbar discectomy and hip and knee arthroplasty: a register-based study. Occup Environ Med 2024;81:150-7.
Soini E, Asseburg C, Pehrsson M, Lundström T, Meretoja T, Hautalahti M, Salminen E, Mäkelä J, Carpén O. From Biobank Sample to Breast Cancer Prevention—Cost-Effectiveness Analysis of Returning Genomic Data to Sample Donors. Value in Health, Volume 26, Issue 11, S2 (December 2023)
Väätäinen S, Soini E, Töyräs J. Should Hospitals Do Contract Research? Costs, Net Monetary Benefit, and Return on Public Sector Investments in Research at Kuopio University Hospital. Value in Health, Volume 26, Issue 11, S2 (December 2023)
Soini E, Hautalahti M, Mäki-Opas T. Kustannusvaikuttavuustiedon merkitys toiminnan suunnittelussa ja päätöksenteossa. DigiSote 2022; Video.
Pentikäinen M, Soini E, Asseburg C, Mankinen P, et al. Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Patients in Finland (FINPAH) – A Descriptive Retrospective Real World Cohort Study Between 2008 and 2020. Value Health 2022;25:12S.
Soini E, Hallinen T, Martikainen J. Comparison of Certified Secure Processing Environments (SPE) – Novel Platforms for Collection, Augmentation, Structuring, Transfer, Management, Analysis, Sharing, Reporting, and Storage of Sensitive Data? Value Health 2022;25:12S.
Soini E, Hallinen T, Martikainen J. Secure Processing Environments (SPE) Are Needed for the Cybersecure Collection and Secondary Use of Personal, Health, and Social Data. Value Health 2022;25:12S. SPESiOR included.
Soini E. Health economic evaluation of gravity-based intravenous infusions in Finland: Digital remote monitoring frees capacity and saves materials. WoCoVa 2022; Video.
Puolitaival A, Savola M, Tuomainen P, Asseburg C, Lundström T, Soini E. Health economic evaluation of gravity-based intravenous infusions in Finland: Digital remote monitoring frees capacity and saves materials. WoCoVa 2022; Podium B11.4.
Ihalmo P, Väätäinen S, Soini E, Vandorou C, Mankinen P, Nevalainen E, Price M. Faster Access to Innovative Therapies with Risk-Sharing Agreements - Cancer Medication Reimbursement Decisions from January 2012 to November 2021 in Finland. Value Health 2022;25:6 S1.
Ihalmo P, Väätäinen S, Soini E, Nevalainen E, Vandorou C, Mankinen P, Price M. Life-Years Gained with Conditional Reimbursement Access to Innovative Oncological and Hematological Medicines in Finland. Value Health 2022;25:6 S1.
Puolitaival A, Savola M, Tuomainen P, Asseburg C, Lundström T, Soini E. Digital Remote Monitoring of Intravenous Infusions Frees Capacity and Saves Materials: Economic Evaluation Study in Finland. Value Health 2022;25:6 S1.
Fingenious ekosysteemitilaisuus 1.12.2021. (Erkki Soinin puhe alkaa 56:00)
Karki S, Ryynänen O-P, Salokekkilä P, & Häggman-Laitila A. 2023. Bayesian analysis of the factors explaining the disruptive behaviour of care leavers: A retrospective document analysis. Children and Youth Services Review, Volume 155, 107174.
Vislisel JM, Zhang J, Dhariwal M, Soini E, Asseburg C, & Karki S. Patient-reported outcomes for spectacle independence with an extended depth of focus intraocular lens: a meta-analysis. AAO, November 3-6, 2023, San Francisco.
Vislisel JM, Zhang J, Dhariwal M, Soini E, Asseburg C, & Karki S. Patient-reported outcomes for visual disturbances with an extended depth of focus intraocular lens: a meta-analysis. ASCRS, May 5-8, 2023, San Diego, CA.
Vislisel JM, Zhang J, Dhariwal M, Soini E, Asseburg C, & Karki S. Patient-reported satisfaction with an extended depth of focus intraocular lens: a meta-analysis. ASCRS, May 5-8, 2023, San Diego, CA.
Asseburg C, Mankinen P, Soini E. (737) Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in Finland Between 2008 and 2020 (FINPAH) - A Descriptive Real-World Cohort Study.
Asseburg C, Oksanen M, Soini E. Triple therapy for incident pulmonary arterial hypertension in Finland between 2008 and 2020. A descriptive real-world FINPAH cohort study.
Hallinen T, Kivelä S, Soini E, et al. Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland. ClinicoEconomics and Outcomes Research 2023;15:1–13.
Purola PKM, Taipale J, Väätäinen S, et al. Price tag of glaucoma care is minor compared with the total direct and indirect costs of glaucoma: Results from nationwide survey and register data. PLoS One 2023;18:e0295523.
Lavikainen P, Hartikainen J, Miettinen H, Viljakainen M, Martikainen J, et al. Agreement between physician- and patient-reported Canadian cardiovascular society scores among patients undergoing elective coronary angiography - The CATS study. PLoS One 2023;18:e0292058.
Alajärvi L, Martikainen J, Timonen J. Experience of the adequacy and appropriateness of pharmaceuticals-related environmental information and preferred information channels among Finns.
Aarnio E, Huupponen R, Martikainen J, Korhonen MJ. Reimbursement and use of oral anticoagulants during 2014-2022 - A register-based study. Explor Res Clin Soc Pharm 2023;11:100284.